The global prinzmetal angina therapeutics market is expected to surpass an impressive valuation of US$ 10.7 Billion in 2023 and is projected to reach US$ 17.2 Billion by 2033, trailing a CAGR of 4.85%. The development of biosimilars and biobetters, growth in diabetic and hypertension population due to unhealthy lifestyle and rise in consumption of alcohol and …
Monthly Archives: February 2023
Heterozygous Familial Hypercholesterolemia (HEFH) Management Market to reach US$ 58.54 Billion by 2033 | FMI
In fiscal year 2023, the market for managing heterozygous familial hypercholesterolemia (HEFH) management is anticipated to be valued US$ 15.11 Billion, up from US$ 13.2 billion in fiscal year 2022. The worldwide market is anticipated to expand at a constant 14.5% CAGR from 2023 to 2033, reaching a value of US$ 58.54 Billion by the end of …
PCSK9 Inhibitors Sales to expand at a 15.8% CAGR from 2023 to 2033
A recently published study by FMI expects the global PCSK9 inhibitors market to augment at a 15.8% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 13 Billion is expected for the market. Monoclonal antibodies are a kind of biologic medicine that inhibits PCSK9. PCSK9 inhibitors bind to and …
Continue reading “PCSK9 Inhibitors Sales to expand at a 15.8% CAGR from 2023 to 2033”
Positive Displacement Pump Market is expected to accumulate a valuation of US$ 21 Billion by the end of 2032
The global positive displacement pumps market is expected to reach a market value of US$ 13.78 billion in 2022 and a market value of US$ 21 billion by 2032, with a CAGR of 4.3% from 2022 to 2032. The increasing application of positive displacement pumps in various end user sectors can be attributed to the market’s growth. …
High Pressure Processing Equipment Market is Estimated to Register a Strong 12.8% CAGR from 2023 to 2033
The global high-pressure processing equipment market size is valued at US$ 333.9 Million in 2023 and is expected to reach a valuation of US$ 1.1 Billion by 2033. The market is likely to register a growth rate of 12.8% through the forecast period. The high pressure processing equipment market is driven by a number of factors, …
Bulk Terminals Market Overview & Competitive Landscape till 2030
Bulk terminals are crucial components of the industrial infrastructure because they guarantee the efficient and safe transportation of vital resources. Despite the COVID-19 pandemic’s current declines in seaborne trade, the world’s minor bulk trade has grown significantly. According to Future Market Insights (FMI) analysts, the amount of minor bulk traded globally has increased to 1.74 billion …
Continue reading “Bulk Terminals Market Overview & Competitive Landscape till 2030”
Mobile Crane Market share is estimated to reach a valuation of US$ 27.2 Billion by the end of 2032
The market for mobile cranes is expected to grow from US$ 15.2 billion in 2022 to nearly US$ 27.2 billion by 2032. The market share of mobile cranes is expected to grow at a moderate CAGR of 6% between 2022 and 2032. The Asia Pacific region led the way in 2021, accounting for 54% of …
Oncolytic Virus Cancer Therapy Market is projected to exhibit a CAGR of 27% from 2023 to 2033
According to a recent study published by Future Market Insights, the market for oncolytic virus cancer therapy is forecast to reach a valuation of US$ 22.86 Million by 2023-end, and will eventually reach US$ 250 Million by 2033, growing at an astronomical CAGR of 27%. Governments in various emerging economies have captured steps to raise awareness about …
Takotsubo Syndrome Therapeutics Market is projected to reach US$ 2.85 Billion in 2033 | FMI
The global takotsubo syndrome therapeutics market is predicted to exceed an impressive valuation of US$ 2.85 Billion in 2033, with a compound annual growth rate (CAGR) of 6.1% estimated from 2023 to 2033. In both industrialized and developing economies, cardiovascular diseases are the leading cause of death. The rising prevalence of cardiovascular problems such as valvular heart …
Congenital Hyperinsulinism Treatment Market value of US$ 100 Million in 2023 | FMI
The global Congenital Hyperinsulinism Treatment Market is expected to garner a market value of US$ 100 Million in 2023 and is expected to accumulate a market value of US$ 179.08 Million by registering a CAGR of6% in the forecast period 2023-2033. The market for Congenital Hyperinsulinism registered a CAGR of 4% in the historical period 2017-2022. The increasing prevalence of Congenital Hyperinsulinism disease is …